Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview

S Mondal, N Adhikari, S Banerjee, SA Amin… - European journal of …, 2020 - Elsevier
Matrix metalloproteinases (MMPs) are zinc dependent proteolytic metalloenzyme. MMP-9 is
one of the most complex forms of matrix metalloproteinases. MMP-9 has the ability to …

Is there new hope for therapeutic matrix metalloproteinase inhibition?

RE Vandenbroucke, C Libert - Nature reviews Drug discovery, 2014 - nature.com
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that form a family of
24 members in mammals. Evidence of the pathological roles of MMPs in various diseases …

MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines

C Ries, V Egea, M Karow, H Kolb, M Jochum, P Neth - Blood, 2007 - ashpublications.org
Human mesenchymal stem cells (hMSCs) represent promising tools in various clinical
applications, including the regeneration of injured tissues by endogenous or transplanted …

Gelatinase-mediated migration and invasion of cancer cells

M Björklund, E Koivunen - Biochimica et Biophysica Acta (BBA)-Reviews …, 2005 - Elsevier
The matrix metalloproteinases (MMP)-2 and-9, also known as the gelatinases have been
long recognized as major contributors to the proteolytic degradation of extracellular matrix …

Matrix metalloproteinase inhibitors as investigational and therapeutic tools in unrestrained tissue remodeling and pathological disorders

J Liu, RA Khalil - Progress in molecular biology and translational …, 2017 - Elsevier
Matrix metalloproteinases (MMPs) are zinc-dependent proteolytic enzymes that degrade
various proteins in the extracellular matrix (ECM). MMPs may also regulate the activity of …

[HTML][HTML] To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition

JA Jacobsen, JLM Jourden, MT Miller… - Biochimica et Biophysica …, 2010 - Elsevier
This short review highlights some recent advances in matrix metalloproteinase inhibitor
(MMPi) design and development. Three distinct approaches to improved MMP inhibition are …

Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease

MM Benjamin, RA Khalil - … Inhibitors: Specificity of Binding and Structure …, 2012 - Springer
Matrix metalloproteinases (MMPs) are proteolytic enzymes that degrade various
components of the extracellular matrix (ECM). MMPs could also regulate the activity of …

Recent advances in MMP inhibitor design

JF Fisher, S Mobashery - Cancer and Metastasis Reviews, 2006 - Springer
The search for an MMP inhibitor with anticancer efficacy is a nearly three-decade endeavor.
This inhibitor is yet to be found. The reasons for this failure include shortcomings in the …

Matrix metalloproteinase inhibition therapy for vascular diseases

AC Newby - Vascular pharmacology, 2012 - Elsevier
The matrix metalloproteinases (MMPs) are 23 secreted or cell surface proteases that act
together and with other protease classes to turn over the extracellular matrix, cleave cell …

Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility

G Dormán, S Cseh, I Hajdú, L Barna, D Kónya, K Kupai… - Drugs, 2010 - Springer
Matrix metalloproteinases (MMPs) play an important role in tissue remodelling associated
with various physiological and pathological processes, such as morphogenesis …